
Mallinckrodt Pharmaceuticals plc is an Irish-American manufacturer of specialty pharmaceuticals, generic drugs and imaging agents. In 2017, it had 5,500 employees and sales of $3.2 billion, of which $2.9 billion was from the U.S. healthcare system. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Mallinckrodt (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
49%
Total
Publications
7.8K
Total Open
Publications
3.8K
Total
Citations
368K
Open Access
Percentage
49%
Total
Publications
7.8K
Total Open
Publications
3.8K
Total
Citations
368K
Breakdown
Publisher Open
13%
Both
22%
Other Platform Open
14%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
990
Hybrid 21%
566
No Guarantees 42%
1.1K
Other Platform Open
Domain 87%
2.4K
Institution 37%
1K
Other Internet 6%
168
Preprint 6%
152
Public 2%
46
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2.4K |
Washington University in St. Louis | Institution | 605 |
doaj.org OAI-PMH Repository | Institution | 495 |
DOI | Other Internet | 120 |
bioRxiv | Preprint | 76 |
California Digital Library | Institution | 71 |
Unknown Repository | Other Internet | 62 |
Europe PMC | Domain | 54 |
Figshare | Public | 45 |
medRxiv | Preprint | 38 |